Conjunctival Melanoma
📧 Sign up to get email alerts when something new happens for Conjunctival Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma [Phase 1]
Phase 1 trial update reports proof of concept for TBio-4101 in combination with lymphodepleting chemotherapy and IL-2 for relapsed/refractor…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma [Phase 1]
A Phase 1 clinical trial evaluating sentinel lymph node biopsy for conjunctival and eyelid melanoma has completed, providing an update on it…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers
Clinical trial update indicating recruitment for a study on sentinel lymph node biopsy in ocular surface and adnexal cancers.
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial of a vaccine therapy for recurrent stage III/IV melanoma not removable by surgery has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Vaccine Therapy in Treating Patients With Advanced Melanoma [Phase 1]
Phase 1 clinical trial of a melanoma vaccine therapy has completed. The study evaluated safety in patients with advanced melanoma, including…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma [Phase 2]
Phase 2 study of lenalidomide, sunitinib, and cyclophosphamide for stage IV eye melanoma (intraocular and conjunctival melanoma) was termina…